Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Hutchison Chi-Med to File for Approval of Two Cancer Drugs in 2016
  China Centralizes Hospital Drug Procurement
  MicuRx Pairs US Phase II Trial of Novel Antibiotic with China Test
  Eddingpharm Gains China Rights To Omega-3 Product in $169 Million Deal
  Eisai to Build New Oral Solid Dose Plant in Suzhou
  TWi Pharma Regains US Rights to Products from Teva
  Georgia State University Out-Licenses Leukemia Drug to China's Cisen Pharma
  3SBio Files for Hong Kong IPO; May Raise up to $500 Million
  Fosun Pharma Rumored to Offer $480 Million for Lumenis of Israel
  Nuance Biotech Targets China and South Africa
 
Login

  

    
   
ChinaBio® Events
Shanghai, China
April 15-16, 2015

>> More events...

Partner Events

China Healthcare Investment Conference
March 31 – April 2, 2015
Shanghai, China

Asia Biotech Invest 2015
May19-21, 2015
Hong Kong, China
>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors